Celldex Therapeutics Statistics

Total Valuation

CLDX has a market cap or net worth of $1.66 billion. The enterprise value is $1.03 billion.

Market Cap	1.66B
Enterprise Value	1.03B

Important Dates

The last earnings date was Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CLDX has 66.41 million shares outstanding. The number of shares has increased by 18.40% in one year.

Current Share Class	66.41M
Shares Outstanding	66.41M
Shares Change (YoY)	+18.40%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	0.28%
Owned by Institutions (%)	91.02%
Float	52.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	285.87
Forward PS	591.07
PB Ratio	2.53
P/TBV Ratio	2.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	177.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.67, with a Debt / Equity ratio of 0.00.

Current Ratio	19.67
Quick Ratio	19.13
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -27.17% and return on invested capital (ROIC) is -19.90%.

Return on Equity (ROE)	-27.17%
Return on Assets (ROA)	-19.08%
Return on Invested Capital (ROIC)	-19.90%
Return on Capital Employed (ROCE)	-35.60%
Revenue Per Employee	$31,129
Profits Per Employee	-$1.07M
Employee Count	186
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.06% in the last 52 weeks. The beta is 1.22, so CLDX's price volatility has been higher than the market average.

Beta (5Y)	1.22
52-Week Price Change	-25.06%
50-Day Moving Average	21.77
200-Day Moving Average	22.33
Relative Strength Index (RSI)	63.59
Average Volume (20 Days)	1,036,614

Short Selling Information

The latest short interest is 7.78 million, so 11.72% of the outstanding shares have been sold short.

Short Interest	7.78M
Short Previous Month	8.47M
Short % of Shares Out	11.72%
Short % of Float	14.71%
Short Ratio (days to cover)	8.06

Income Statement

In the last 12 months, CLDX had revenue of $5.79 million and -$199.61 million in losses. Loss per share was -$3.01.

Revenue	5.79M
Gross Profit	-193.22M
Operating Income	-234.75M
Pretax Income	-150.22M
Net Income	-199.61M
EBITDA	-231.41M
EBIT	-234.75M
Loss Per Share	-$3.01

Full Income Statement

Balance Sheet

The company has $630.34 million in cash and $3.03 million in debt, giving a net cash position of $627.31 million or $9.45 per share.

Cash & Cash Equivalents	630.34M
Total Debt	3.03M
Net Cash	627.31M
Net Cash Per Share	$9.45
Equity (Book Value)	655.41M
Book Value Per Share	9.87
Working Capital	615.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$186.19 million and capital expenditures -$2.29 million, giving a free cash flow of -$188.48 million.

Operating Cash Flow	-186.19M
Capital Expenditures	-2.29M
Free Cash Flow	-188.48M
FCF Per Share	-$2.84

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-4,054.40%
Pretax Margin	-3,447.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.40%
Shareholder Yield	-18.40%
Earnings Yield	-12.05%
FCF Yield	-11.38%

Dividend Details

Analyst Forecast

The average price target for CLDX is $51.86, which is 108.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$51.86
Price Target Difference	108.32%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	149.42%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 11, 2019. It was a reverse split with a ratio of 1:15.

Last Split Date	Feb 11, 2019
Split Type	Reverse
Split Ratio	1:15

Scores

CLDX has an Altman Z-Score of 25.5 and a Piotroski F-Score of 1.

Altman Z-Score	25.5
Piotroski F-Score	1